3 results match your criteria: "Second Maternal and Child Health Hospital of Jinan City[Affiliation]"
[Clinical Efficacy of ALL-2005 and ALL-2009 Regimen and Factors Influencing Prognosis of Newly Diagnosed ALL Patients Aged between 10-18 Years Old].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
December 2020
Second Department of Pediatrics, Second Maternal and Child Health Hospital of Jinan City, Jinan 271119, Shandong Province, China E-mail:
Objective: To investigate the clinical efficacy of ALL-2005 and ALL-2009 regimen and factors influencing prognosis of newly diagnosed ALL patients aged between 10-18 years old to provide some reference for clinical diagnosis and treatment.
Methods: The clinical data including baseline clinical characteristics, induction chemotherapy effect, long-term clinical efficacy, recurrence rate and mortality of induction therapy of 119 newly diagnosed ALL patients aged between 10-18 years old from January 2008 to December 2015 were analyzed retrospectively, and the influencing factors of clinical prognosis were evaluated by univariate and multivariate analysis.
Results: The complete remission rate at the 5th week after induction therapy was not significantly different between ALL-2005 and ALL-2009 regimen groups (P＞0.
MiR-21 promotes proliferation and inhibits apoptosis of ovarian cancer cells via targeted regulation of jagged-1 pathway.
Panminerva Med
July 2019
Department of Obstetrics, Second Maternal and Child Health Hospital of Jinan City, Jinan, China -
Effects of MiR-155 on trophoblast apoptosis in placental tissues of preeclampsia rats through HIF-1α signaling pathway.
Panminerva Med
September 2021
Department of Obstetrics, Second Maternal and Child Health Hospital of Jinan City, Jinan, China -